secwatch.observer — SEC 8-K summary
======================================

Issuer:     MiniMed Group, Inc. (MMED)
CIK:        0002062583
Form:       8-K
Filed at:   2026-03-09T23:59:59+00:00
Accession:  0001628280-26-016018
Event type: other_material
Sentiment:  neutral
Materiality: 1.00
Item codes: 1.01, 2.01, 2.03, 3.02, 3.03, 5.03, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MiniMed Group completes IPO, raises ~$560M; Medtronic retains 90% ownership
---------------------------------------------------------------------------

- IPO of 28M shares at $20/share; net proceeds ~$560M; $309M retained for corporate purposes, excess repays Medtronic intercompany debt.
- Medtronic owns ~90% post-IPO; Separation completed via merger with KH2 and transfer of Medtronic's Diabetes business assets.
- New 9-member board appointed with Kevin Lofton as Chair; officers include CEO Que Dallara, CFO Chad Spooner, etc.
- $500M revolving credit facility established upon IPO closing for working capital and general corporate purposes.
- Separation agreements filed governing tax, employee benefits, IP cross-licenses, transition services, and supply arrangements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2062583/000162828026016018/0001628280-26-016018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2062583/000162828026016018/mmed-20260305.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-016018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer